MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Authors:
Open Access
- 4 April 2023
- journal article
- review article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 32, 371-384
Abstract
No abstract availableKeywords
Funding Information
- University of Campania Luigi Vanvitelli (IZS ME 09/22 RC- STUPORANIMA, PON I&C 2014-2020-CAPSULE-F/200016/01-03/X45, PON I&C 2014–2020-TABAREZO-F/200085/01-03/X45)
This publication has 145 references indexed in Scilit:
- Non-coding RNAs as a new dawn in tumor diagnosisSeminars in Cell & Developmental Biology, 2018
- Evaluating Nanomedicines: Obstacles and Advancements2017
- MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cellsOncotarget, 2017
- miRNA nanotherapeutics for cancerDrug Discovery Today, 2017
- Evaluation of the cytotoxic effects of hyperthermia and 5-fluorouracil-loaded magnetic nanoparticles on human colon cancer cell line HT-29International Journal of Hyperthermia, 2016
- Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticlesBioorganic & Medicinal Chemistry Letters, 2013
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Nanodiamonds as vehicles for systemic and localized drug deliveryExpert Opinion on Drug Delivery, 2009
- Methods for the Preparation and Manufacture of Polymeric NanoparticlesPharmaceutical Research, 2008
- Comment on “Paired Gap States in a Semiconducting Carbon Nanotube: Deep and Shallow Levels”Physical Review Letters, 2007